Company Filing History:
Years Active: 2019-2020
Title: Michal Tur Sinai: Innovator in CFTR Gene Modulation
Introduction
Michal Tur Sinai is a prominent inventor based in Mevaseret Zion, Israel. He has made significant contributions to the field of genetic research, particularly in the modulation of the CFTR gene, which is crucial for various cellular functions.
Latest Patents
Tur Sinai holds 2 patents related to the restoration of CFTR function through splicing modulation. His first patent provides oligonucleotides capable of binding to and modulating the splicing of the pre-mRNA of the CFTR gene. This innovation includes compositions and kits that utilize these oligonucleotides for therapeutic applications. Specifically, the patent addresses methods for suppressing exon skipping, which can enhance the efficacy of additional CFTR therapeutics. His second patent mirrors the first, focusing on oligonucleotides that modulate splicing and suppress exon 10 skipping, further emphasizing the potential for combined therapeutic strategies.
Career Highlights
Tur Sinai is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at Yissum has positioned him at the forefront of research and development in genetic therapies, particularly those targeting cystic fibrosis and related disorders.
Collaborations
Throughout his career, Tur Sinai has collaborated with notable colleagues, including Batsheva Kerem and Loren Price. These partnerships have fostered a collaborative environment that enhances the innovation process and accelerates the development of new therapeutic solutions.
Conclusion
Michal Tur Sinai's contributions to the field of genetic research, particularly through his patents on CFTR gene modulation, highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic therapies, offering hope for improved treatments for genetic disorders.